IP Library Granted Patent US 10,426,849
Granted Patent B2
US 10,426,849 · App. 15/422,961 · Granted Oct 1, 2019

Staining composition

Inventor: Gerrit Reinold Jacob Melles (Rotterdam, NL)
Assignee: D.O.R.C. Dutch Ophthalmic Research Center (International) B.V.
A61K49/001A61K49/003A61K49/006A61K49/0023A61K49/0028A61K49/0034A61K49/0071A61K9/0048
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,426,849
App. No.
15/422,961
Granted
Oct 1, 2019
Kind
B2
Abstract

The invention is directed to a staining composition and to the use of the staining composition in staining ocular tissue. In a first aspect, the invention provides a staining composition comprising a vital dye and a density increasing compound chosen from the group consisting of water soluble polymers and small inert molecules.

Claims (10)

1. A staining composition, comprising hyaluronic acid and a dye combination comprising Chicago Sky Blue 6B and trypan blue (TB).

2. The staining composition according to claim 1 , wherein the concentration of a dye in the dye combination is 0.001-2 wt. %, based on the total weight of the staining composition.

3. The staining composition according to claim 1 , further comprising a salt buffer.

4. The staining composition according to claim 1 , wherein the salt buffer has an osmolarity of between 250 and 400 mosmol/L.

5. The staining composition according to claim 1 , wherein the salt buffer is phosphate buffered NaCl.

6. The staining composition according to claim 1 , wherein the pH is 6.5-7.5.

7. A method of treatment comprising staining an ocular tissue or part of an ocular tissue with a staining composition, which staining composition comprises hyaluronic acid and a dye combination comprising Chicago Sky Blue 6B and trypan blue (TB).

8. The method according to claim 7 , wherein the staining is part of an eye surgery.

9. A staining composition according to claim 8 , wherein the eye surgery is cataract extraction.

10. A method for preparing a staining composition according to claim 5 , comprising the step of dissolving hyaluronic acid and a dye combination comprising Chicago Sky Blue 6B and trypan blue (TB), and optionally dissolving a salt in the liquid to adjust the osmolarity of the liquid to a value between 250 and 400 mosmol/L.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 19, 2018
From: FENELON HOLLAND HOLDING B.V.
To: D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER (INTERNATIONAL) B.V.
Reel/Frame 047814/0412 →
CHANGE OF NAME Recorded Dec 14, 2018
From: MEDICAL TECHNOLOGY TRANSFER HOLDING B. V.
To: FENELON HOLLAND HOLDING B.V.
Reel/Frame 047774/0717 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 5, 2018
From: MELLES, GERRIT REINOLD JACOB
To: MEDICAL TECHNOLOGY TRANSFER HOLDING B.V.
Reel/Frame 047722/0267 →
Priority Claims (2)
EP 10159021 · Apr 1, 2010 · regional
EP 10164866 · Jun 3, 2010 · regional
Continuity (2)
Continuation 13638105
Related Publication 20170258939A1 · Sep 14, 2017